Latigo Biotherapeutics adopts amended and restated bylaws tied to IPO close
LTGO•Bylaws and charter changes effective at IPO close
Latigo Biotherapeutics adopted amended and restated bylaws effective Aug. 10, 2026 in connection with its IPO closing.
It also filed an amended and restated certificate of incorporation in Delaware, effective immediately before the IPO close.
IPO raised about $345.6 million in gross proceeds
The IPO sold 19,200,000 common shares at $18 per share, raising about $345.6 million in gross proceeds.
Related News
Morgan Stanley to facilitate about $1.5 trillion to finance US innovation over 10 years
MS•
Apollo Commercial Real Estate Finance posts Q2 net income of $0.11 per share, hit by realized investment losses
ARI•
